BISSANTZ, CATERINA,GRUNDSCHOBER, CHRISTOPHE,NETTEKOVEN, MATTHIAS,PLANCHER, JEAN-MARC,VIFIAN, WALTER
申请号：
CA2898015
公开号：
CA2898015A1
申请日:
2014.01.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The invention relates to the use of a compound of formula I wherein A1 is phenyl or a five or six membered hereroaryl group, containing 1, 2 or 3 heteroatoms, selected from N or S； R1 is hydrogen, lower alkyl, halogen, lower alkyl substituted by halogen or cycloalkyl； A2 is phenyl； R2 is halogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy substituted by halogen, cyano, S-lower alkyl substituted by halogen, S(O)2-lower alkyl substituted by halogen； n is 1 or 2； or a to pharmaceutically acceptable acid addition salt, to a racemic mixture or to its corresponding enantiomer and/or optical isomers thereof for the treatment of autism, stress, including post traumatic stress disorder, anxiety, including anxiety disorders and depression, schizophrenia, psychiatric disorders and memory loss, alcohol withdrawel, drug addiction and for the treatment of Prader-Willi Syndrom.
